Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

    Funding for research on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD) across the lifespan with the aim of reducing prenatal alcohol exposure and advancing intervention methods.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

    This grant supports research on preventing and treating fetal alcohol spectrum disorders (FASD) through a phased approach, with a focus on clinical trials.

    HHS-NIH11Due Nov 17, 2026· 19d$1,850,000

    Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)

    An anticipated NIH funding opportunity will support collaborative consortium research on fetal alcohol spectrum disorders, including diagnosis, interventions, mechanisms, and prevention.

    HHS-NIH11Forecasted Sep 25, 2027Forecasted

    HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

    NIH funds milestone-driven research to develop, pilot, and expand testing of HIV prevention interventions, including approaches addressing alcohol use and related comorbidities.

    HHS-NIH11Forecasted Sep 7, 2027Forecasted

    Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

    Supports pilot and feasibility studies to prepare substance use and HIV intervention and services research trials, including prevention, treatment, and recovery research.

    HHS-NIH11Due Feb 16, 2027$450,000

    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

    Funding available for pilot research to improve access and effectiveness of treatments for drug, alcohol, and tobacco use disorders, including comorbid conditions.

    HHS-NIH11Due Nov 16, 2026· 18d$450,000